Reagent-Free Preparative Transient Transfection

MaxCyte's ITF Inline Transfection System is a validated platform for preparative transfection using flow electroporation. The system enables rapid and efficient transfection of any kind of cell or cell line, with any molecule (plasmids, proteins, protein complexes, drugs, mRNA, siRNA), at any scale.

MaxCyte's ITF Inline Transfection System enables transient transfection of cell lines as well as primary cells, and it is now available for drug discovery and screening purposes. The sterile, closed system provides unparalleled consistency, scalability, and loading efficiency while avoiding the inherent drawbacks of alternative methods.

The MaxCyte Advantage

  • Any Molecule into Any Cell
    • Primary cells, stem cells, or cell lines
    • Plasmids, mRNA, siRNA, proteins, protein complexes, protein lysates

  • Any Scale
    • 500 – 5,000 x10E6 cells/minute
      < 1 ml to 100 ml of cell suspension per run (0.5e6 – 10e9 cells)

  • High Yield
    • > 90% viability & recovery in most cell lines
    • Increased throughput, cell-loading efficiency and viability without additional optimization

  • High Efficiency
    • > 90% cell loading & transfection efficiency in most cell lines.

Table of Primary Cells

Table of Cell Lines

Please contact us for additional information:

ITFinfo@maxcyte.com or Contact.

MaxCyte's technology is protected by U.S. and international patents. The ITF Inline Transfection System is available for royalty free non-clinical research and screening applications under a limited label license. Clinical applications require a special license and agreement with MaxCyte. Please contact us for details.